Edwards Lifesciences
1,152 hedge funds and large institutions have $47.8B invested in Edwards Lifesciences in 2020 Q4 according to their latest regulatory filings, with 163 funds opening new positions, 406 increasing their positions, 390 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4% more repeat investments, than reductions
Existing positions increased: 406 | Existing positions reduced: 390
0.22% less ownership
Funds ownership: 82.86% → 82.64% (-0.22%)
16% less funds holding in top 10
Funds holding in top 10: 19 → 16 (-3)
Holders
1,152
Holding in Top 10
16
Calls
$235M
Puts
$127M
Top Buyers
| 1 | +$219M | |
| 2 | +$216M | |
| 3 | +$130M | |
| 4 |
Bank of New York Mellon
New York
|
+$108M |
| 5 |
SFFS
Stonehage Fleming Financial Services
St. Helier,
Jersey
|
+$85.8M |
Top Sellers
| 1 | -$193M | |
| 2 | -$177M | |
| 3 | -$161M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$111M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$110M |